Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 23.05.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.05.23BlackRock Sustainable American Income Trust - Unique value and ESG strategy222Since July 2021, BlackRock Sustainable American Income Trust (BRSA) has integrated explicit ESG objectives into its investment strategy. Managers Tony DeSpirito, David Zhao and Lisa Yang aim to deliver...
► Artikel lesen
23.05.23Murray Income Trust - Milestones marked by a return to form418Murray Income Trust (MUT) marks its 100-year anniversary this year. It invests mainly in UK equities and aims to provide capital growth and a high and growing income. The trust continues to meet these...
► Artikel lesen
23.05.23The Pebble Group - H123 trading ahead of prior year350The Pebble Group's AGM statement outlines first-half trading likely to be up on the same period in FY22, with both of the group's constituent businesses performing well. Facilisgroup, serving the US...
► Artikel lesen
23.05.23Dowlais Group - Positive start to the year389Management set out its strategy when the company listed in April. The trading update confirms that it is on track. Volume and top-line growth, as reported, are expected to provide leverage over the...
► Artikel lesen
23.05.23Respiri - Telehealth acquisition to bolster US roll-out388In a strategic push of its US commercialisation strategy, Respiri has announced the proposed acquisition of Access Managed Services, its US remote patient monitoring (RPM) and chronic care management...
► Artikel lesen
23.05.23Immix Biopharma - A quarter focusing on a CAR-T strategy421Following recent updates regarding Immix's CAR-T therapy (NXC-201) and Q123 results, we have adjusted our financial estimates. Quarterly R&D expenses of $1.3m were lower than expected, largely due to...
► Artikel lesen
23.05.23Mendus - Sights on vididencel (in AML) combination study411On the heels of Mendus's recent Q123 results, we take a deep dive into the company's lead cancer vaccine candidate, vididencel, and the acute myeloid leukaemia (AML) maintenance treatment landscape....
► Artikel lesen
23.05.23Melrose Industries - The stars are aligned454Following the demerger of Dowlais automotive, Melrose Industries is a focused aerospace group with a retuned strategy, still with shareholder value at its core, to develop its capabilities long term...
► Artikel lesen